J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice

The Food and Drug Administration has categorized an urgent medical device correction from Johnson & Johnson’s Megadyne as a Class I event.
Megadyne contacted customers last month to restrict the use of four electrode products in children under the age of 12 years. The products are staying on the market with a narrower label.